Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity

被引:0
作者
Tracy C. Kuo
Amy Chen
Ons Harrabi
Jonathan T. Sockolosky
Anli Zhang
Emma Sangalang
Laura V. Doyle
Steven E. Kauder
Danielle Fontaine
Sangeetha Bollini
Bora Han
Yang-Xin Fu
Janet Sim
Jaume Pons
Hong I. Wan
机构
[1] ALX Oncology,Department of Pathology
[2] University of Texas Southwestern Medical Center,undefined
[3] Tallac Therapeutics,undefined
[4] Genentech,undefined
[5] Coherus BioSciences,undefined
[6] ProLynx Inc.,undefined
来源
Journal of Hematology & Oncology | / 13卷
关键词
SIRPα; CD47; Macrophage; Phagocytosis; Immunotherapy; Innate immune checkpoint; Adaptive immunity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 261 条
[21]  
Bortone DS(2002)The contrasting IgG-binding interactions of human and herpes simplex virus Fc receptors Biochem Soc Trans 30 495-147
[22]  
Ou Yang TH(2000)In vitro characterization of five humanized OKT3 effector function variant antibodies Cell Immunol 200 16-713
[23]  
Veglia F(2001)High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R J Biol Chem 276 6591-373 e5
[24]  
Gabrilovich DI(1995)The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding Immunology 86 319-E7249
[25]  
Matlung HL(1983)Blockade of Fc receptor-mediated binding to U-937 cells by murine monoclonal antibodies directed against a variety of surface antigens J Immunol 131 140-41
[26]  
Szilagyi K(2010)Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma Cell 142 699-1100
[27]  
Barclay NA(2019)Functional characterization of the selective pan-allele anti-SIRPalpha antibody ADU-1805 that blocks the SIRPalpha-CD47 innate immune checkpoint J Immunother Cancer 7 340-1161 e7
[28]  
van den Berg TK(2017)Dendritic cells but not macrophages sense tumor mitochondrial DNA for cross-priming through signal regulatory protein alpha signaling Immunity 47 363-31125
[29]  
Veillette A(2016)Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cells Proc Natl Acad Sci USA 113 E7240-953
[30]  
Chen J(2017)Rational selection of syngeneic preclinical tumor models for immunotherapeutic drug discovery Cancer Immunol Res 5 29-2357